Prescriptions for controversial drug shot up 250% for cancer patients after Mel Gibson endorsement

by antebulletins
0 comments

The findings raise concerns that patients may be skipping or delaying proven treatments in favor of the off-label regimen. 

You may also like

Leave a Comment